WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7201 Infant (under 12 months) mortality rate: 1172
GDP / capita (US$): 2'0531 Child (under 5 years) mortality rate: 1822

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 6'205  6'092  5'979  5'865  5'752  4'140  4'043  3'180 
Births 224  223  222  222  220  187  174  154 
Surviving infants 199  197  196  195  194  160  147  130 
Pop. less than 5 years 942  935  928  921  915  703  700  579 
Pop. less than 15 years 2'559  2'532  2'499  2'464  2'425  1'778  1'805  1'394 
Female 15-49 years 1'536  1'501  1'467  1'435  1'404  991  912  715 

Number of reported case

(Click for retrospective incidence data for Sierra Leone)
Diphtheria
Japanese encephalitis
Measles 1'006  15  678  1'865  1'089  3'575  830  3'625 
Mumps
Pertussis 23  1'619 
Polio* 34  38  11 
Rubella 54 
Rubella (CRS)
Tetanus (neonatal) 23  56  36  26 
Tetanus (total)** 112  36  103  871 
Yellow fever 94  361 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sierra Leone)
Vaccine year result method % card seen                                                
BCG 2012  96  DHS   73  90  99  97  90  90  39  98  36 
DTP1 2012  94  DHS   73  88  98  91  80  80  33 
DTP3 2012  78  DHS   73  83  92  91  76  76  24  83  13 
DTP4         
IPV1         
HepB_BD         
HepB3 2012  78  DHS   73  83  92  91  76  76 
Hib3 2012  78  DHS   73  83  92  91  76  76 
JapEnc         
MCV1          80  85  88  75  70  43  75  36 
MCV2         
PCV1          88  98  80  85 
PCV3 2012  92  EPI   93  83  92  80  75 
Pol3 2012  78  DHS   73  83  92  91  76  76  26  83 
Rota1          85 
Rota_last          70 
Rubella1         
TT2plus 2012  81  EPI   93  90  81  60  90  90  20  81 
PAB         
VAD1          80  88  99*  73  20 
YFV 2012  84  EPI   93  80  85  88  75  70 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sierra Leone)
BCG 90  99  98  97  97  74 
DTP1 88  98  98  97  95  64 
DTP3 83  92  91  89  86  44 
HepB3 83  92  91  89  86 
HepB_BD
Hib3 83  92  91  89  86 
MCV1 78  83  84  83  81  37 
MCV2
PAB 85  87  87  85  85  53  85 
PCV3 83  92  92  75 
Pol3 83  92  91  88  84  46 
Rota_last 53 
YFV 80  85  85  83  82 

Number of districts in the country 14  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 57
From 80 to 89% 36
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From January 2016
MR From November 2017
Measles 9 months; 15 months (from May 2016); Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2017  2012 - 2016  2007 - 2011  2007 - 2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 14  14  14  14  14  13  13 

System performance

Total Nº districts in country number 14  14  14  14  14  14  14 
Nº districts with DTP3 coverage >=80% number 13  13  14  13  11  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  93  100  93  79  86  57 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 29  36  29  21  36  57  14 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  No  No   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 22         

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.